![Barry Quart](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 2 M $ in data 31/07/2026
Barry D.
Quart was the founder of Ardea Biosciences, Inc., founded in 2006, where the titles held included President, Chief Executive Officer & Director from 2012 to 2013.
Current jobs include Chief Executive Officer & Director at Connect Biopharma Holdings Ltd. starting in 2024; Director at NeuroGenetic Pharmaceuticals, Inc.; Independent Director at Kiniksa Pharmaceuticals Ltd. since 2015; Director at Kiniksa Pharmaceuticals Corp.; and Independent Director at Kiniksa Pharmaceuticals International Plc starting in 2024.
Former jobs include Chairman & Chief Executive Officer at Heron Therapeutics, Inc. from 2020 to 2023; Director at Trimeris, Inc. from 2007 to 2011; Director, SVP-Global Research & Development at Pfizer (La Jolla); Independent Director at Synageva BioPharma Corp.
from 2012 to 2015; President-Research & Development at Agouron Pharmaceuticals LLC; Senior VP-Pfizer Global Research & Development at Pfizer Inc.; and President at Napo Pharmaceuticals, Inc. from 2002 to 2006.
Education includes a doctorate from The University of California, San Francisco.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
0,03% | 29/05/2026 | 15.345 ( 0,03% ) | 1 M $ | 31/07/2026 |
| 16/03/2026 | 224.034 ( 0,4% ) | 452 549 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CONNECT BIOPHARMA HOLDINGS LIMITED | Amministratore Delegato | 12/06/2024 |
NeuroGenetic Pharmaceuticals, Inc.
 NeuroGenetic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the prevention of neurodegenerative conditions | Direttore/Membro del Consiglio | - |
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Direttore/Membro del Consiglio | 01/10/2015 |
Kiniksa Pharmaceuticals Corp.
 Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes therapeutic medicines for patients suffering from debilitating diseases | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| HERON THERAPEUTICS, INC. | Amministratore Delegato | 03/04/2023 |
| SYNAGEVA BIOPHARMA CORP | Direttore/Membro del Consiglio | 22/06/2015 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Fondatore | 01/05/2013 |
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for viral diseases | Direttore/Membro del Consiglio | 04/11/2011 |
Napo Pharmaceuticals, Inc.
 Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets human gastrointestinal pharmaceuticals | Presidente | 01/12/2006 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 13 |
|---|---|
Heron Therapeutics, Inc.
 Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and distributes therapeutic products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for viral diseases | Health Technology |
Napo Pharmaceuticals, Inc.
Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets human gastrointestinal pharmaceuticals | Health Technology |
NeuroGenetic Pharmaceuticals, Inc.
NeuroGenetic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the prevention of neurodegenerative conditions | Health Technology |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
Pfizer (La Jolla)
 Pfizer (La Jolla) Miscellaneous Commercial ServicesCommercial Services Provides research services | Commercial Services |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
Kiniksa Pharmaceuticals Corp.
Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes therapeutic medicines for patients suffering from debilitating diseases | Health Technology |
Connect Biopharma Holdings Ltd.
 Connect Biopharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
